WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) released a profit
for its first quarter that increased from the same period last year and beat
the Street estimates.

The company's bottom line came in at $88.66 million, or $0.46 per share. This
compares with $50.85 million, or $0.27 per share, in last year's first quarter.

Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of
$139.7 million or $0.71 per share for the period.

Analysts on average had expected the company to earn $0.34 per share, according
to figures compiled by Thomson Reuters. Analysts' estimates typically exclude
special items.

The company's revenue for the quarter rose 8.8% to $648.83 million from $596.42
million last year.

Biomarin Pharmaceutical Inc. earnings at a glance (GAAP) :

-Earnings (Q1): $88.66 Mln. vs. $50.85 Mln. last year.
-EPS (Q1): $0.46 vs. $0.27 last year.
-Revenue (Q1): $648.83 Mln vs. $596.42 Mln last year.

-Guidance:
Full year EPS guidance: $2.75 - $2.95


Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX